474013-77-9

Basic information

• Product Name: 5,10-dioxo-5H,10H-diimidazolo[1,5-a:1',5'-d]pyrazine-1,6-dicarboxylic acid diphenyl ester
• Synonyms: 5,10-dioxo-5H,10H-diimidazolo[1,5-a:1',5'-d]pyrazine-1,6-dicarboxylic acid diphenyl ester
• CAS NO: 474013-77-9
• Molecular Weight: 428.36
• Mol File: 474013-77-9.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: 5,10-dioxo-5H,10H-diimidazolo[1,5-a:1',5'-d]pyrazine-1,6-dicarboxylic acid diphenyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 5,10-dioxo-5H,10H-diimidazolo[1,5-a:1',5'-d]pyrazine-1,6-dicarboxylic acid diphenyl ester(474013-77-9)
• EPA Substance Registry System: 5,10-dioxo-5H,10H-diimidazolo[1,5-a:1',5'-d]pyrazine-1,6-dicarboxylic acid diphenyl ester(474013-77-9)

Safety Data

• Hazardous Substances Data: 474013-77-9(Hazardous Substances Data)

Upstream product

• 59399-36-9 imidazole-4,5-dicarboxylic acid chloride 
• 108-95-2 phenol 
• 570-22-9 4,5-imidazoledicarboxylic acid 
• 59157-06-1 4H,9H-diimidazo<1,5-a; 1',5'-d>pyrazine-5,10-dione-1,6-dicarboxylic dichloride 

Downstream Products

• 1454887-79-6 phenyl 4-(p-tolylcarbamoyl)-1H-imidazole-5-carboxylate 
• 1454887-80-9 phenyl 4-((2-(benzyloxy)phenyl)carbamoyl)-1H-imidazole-5-carboxylate 
• 575497-25-5 4-((4-fluorophenyl)carbamoyl)-1H-imidazole-5-carboxylic acid 
• 1454887-71-8 4-((4-fluorobenzyl)carbamoyl)-1H-imidazole-5-carboxylic acid 
• 436088-75-4 4-(pyridine-2-ylcarbamoyl)-1H-imidazole-5-carboxylic acid 
• 1454887-78-5 C₁₆H₁₂N₄O₃ 
• 500202-08-4 4-((4-nitrophenyl)carbamoyl)-1H-imidazole-5-carboxylic acid 
• 436088-52-7 4-((4-aminophenyl)carbamoyl)-1H-imidazole-5-carboxylic acid 

Relevant articles and documents

AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES

The present invention relates to amido-substituted cyclohexane compounds of general formula (I) : in which m, A, R4, R6, R7, R8, R9, R10 and R11 are as defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of neoplasms, as a sole agent or in combination with other active ingredients.

AMIDO-SUBSTITUTED AZOLE COMPOUNDS

The present invention relates to amido-substituted azole compounds of general formula (I), in which X1, X2, R1, R2, R4, R5, R7 and R8 are as defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of neoplasms, as a sole agent or in combination with other active ingredients.

AMIDO-SUBSTITUTED AZOLE COMPOUNDS

The present invention relates to amido-substituted azole compounds of general formula (I), in which X1, X2, R1, R2, R4, R5, R7 and R8 are as defined in the claims which are inhibitors of TNKS1 and/or TNKS2, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of neoplasms, as a sole agent or in combination with other active ingredients.